‹ All stocks

Oruka Therapeutics

ORKA · NASDAQ · Healthcare

$77.28

▼ $2.22 (-2.79%)

1D 7D 1M 3M 1Y

Day range

$75.83 – $80.19

Year range

$21.66 – $115.52

Open

$78.47

Previous close

$79.50

Market cap

$4.66B

Volume (24h)

$1.2M

Volume (52w)

$94.67M

Performance

▼ -8.57%

▼ -15.54%

▼ -8.61%

▲ 25.90%

▲ 202.47%

YTD

▲ 173.36%

▲ 214.15%

▲ 139.41%

All-time

▼ -100.00%

Key statistics

P/E ratio

-38.07

EPS (TTM)

$-2.03

Dividend yield

—

Dividend (TTM)

—

Payout ratio

—

Shares outstanding

60.3M

About Oruka Therapeutics

Oruka Therapeutics, Inc. functions as a biotechnology firm primarily dedicated to creating groundbreaking monoclonal antibody therapies. These treatments are designed to address Psoriasis (PsO) along with various other inflammatory and immunological (I&I) conditions. Its current development portfolio includes ORKA-001 and ORKA-002. The company's main operations are based in Menlo Park, CA.

Visit website

Country: United States of America

LLY Eli Lilly and Company	$1169.60	-1.61%
JNJ Johnson & Johnson	$256.48	-0.76%
ABBV AbbVie	$272.42	0.39%
MRK Merck & Co.	$142.38	-0.29%
UNH UnitedHealth Group Incorp…	$370.95	-1.34%